Michael Widlansky, MD
Enriched profileNorthwestern Mutual Professor of Cardiovascular Medicine; Director, Cardiovascular Research Center; Professor of Medicine and Pharmacology & Toxicology · Medical College of Wisconsin
Michael Widlansky is Northwestern Mutual Professor of Cardiovascular Medicine; Director, Cardiovascular Research Center; Professor of Medicine and Pharmacology & Toxicology at Medical College of Wisconsin. OpenAlex indexes 172 publications with 9,340 citations (h-index 34); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Michael Widlansky, MD, is Northwestern Mutual Professor of Cardiovascular Medicine at Medical College of Wisconsin. The public record shows 172 publications with 9,340 citations (h-index 34), centered on Coronary Artery Disease / ACS, Heart Failure. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 2 companies, 10 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2025 · Nature communications
- Top research focus: Coronary Artery Disease / ACS
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Pilot Study Lp299v Supplementation in Chronic Heart Failure
Sponsor: Medical College of Wisconsin
- Vascular Aging and Lp299v Study in Healthy Adults
Sponsor: Medical College of Wisconsin
- Impact of Lp299v on Vascular Function in Patients With PASC
Sponsor: Medical College of Wisconsin
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
- Eli Lilly and CompanyProgram year20221 payment
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Nitrate100%Nitroglycerin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
10 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Human Coronary Artery Plaque Transcriptomes and Cardiovascular Risk Assessment
Medical College of Wisconsin
FY2026$665,481R01HL173778 - Medical College of Wisconsin Physician Scientist Immersion Program
Medical College of Wisconsin
FY2026$191,864R38HL167238 - Cardiometabolic Impact of Gender-Affirming Hormone Therapy in Transmasculine Young Adults
Medical College of Wisconsin
FY2025$779,771R01HL177518
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Chromatin interaction maps of human arterioles reveal mechanisms for the genetic regulation of blood pressure.
Nature communications
Article2025 - Chromatin State Maps of Blood Pressure-Relevant Renal Segments Reveal Potential Regulatory Role for SNPs.
Hypertension (Dallas, Tex.
Article2025 - Role of the circulating milieu in age-related arterial dysfunction: a novel ex vivo approach.
American journal of physiology. Heart and circulatory physiology
Article2024 - Coronary Plaque Sampling Reveals Molecular Insights Into Coronary Artery Disease.
Circulation research
Article2023
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/mwidlansky
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Michael-Widlansky
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Doximity
doximity.com/pub/michael-widlansky-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/Cardiovascular.Center.MCW/posts/michael-e-widlansky-md-mph-northwestern-mutual-professor-in-cardiovascular-medic/1055674659894066
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
ventureinvestorshealthfund.medium.com/going-beyond-glucose-targeting-the-root-of-diabetic-vascular-disease-b6afc5bdb0bb
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ventureinvestorshealthfund.medium.com ↗ - LinkedIn
LinkedIn: linkedin.com/in/mwidlansky (Director, Cardiovascular Research Center, MCW)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Board Certified
Cardiovascular Disease (ABIM)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Board Certified
Internal Medicine (ABIM)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Fellow
American College of Cardiology (FACC)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharecare.com ↗
Editorial & leadership roles
journal and society appointments- Member
American Heart Association scientific councils: Council on Lifestyle and Cardiometabolic Health, Council on Epidemiology and Prevention, Council on Clinical Cardiology, Council on Genomic and Precision Medicine …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fcd.mcw.edu ↗ - Chair
Human Research Affairs Committee, MCW Division of Cardiovascular Medicine
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fcd.mcw.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fcd.mcw.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fcd.mcw.edu ↗
Secondary affiliations
appointments beyond the home institution- Department of Medicine
Division of Cardiovascular Medicine, Medical College of Wisconsin (Academic Chief / Associate Chief for Academic Affairs; Cardiovascular Fellowship Director)
- Director
Human Vascular Translational Research Core, MCW Cardiovascular Research Center
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Janet Rader, MD
Medical College of Wisconsin
Bruce Camitta, MD
Medical College of Wisconsin